Covid-19 has spurred increased funding and interest in life sciences research, a trend that LLR Partners hopes to capitalize on through its acquisition of a majority stake in lab products manufacturer Genesee Scientific, announced earlier in October.
To read the entire story, you must be logged in.
Please log in now or register with us.
